Does insurance or Medicare cover GLP-1s for weight loss?

Medicare: what the GLP-1 Bridge covers

Medicare coverage by drug, checked Oct 17, 2026

Drug	Under the GLP-1 Bridge (weight management)	Through your regular Part D plan	Source
Zepbound KwikPen	Covered, $50 a month	Might be covered for moderate to severe sleep apnea	[1] [2]
Zepbound vials and single-dose pens	Not covered	Might be covered for sleep apnea, per plan	[1] [2]
Wegovy pen or pill	Covered, $50 a month	Ask your plan about heart-risk or fatty liver uses	[1] [2]
Foundayo	Covered, $50 a month	Not applicable	[1]
Ozempic	Not covered	Might be covered for type 2 diabetes	[1] [2]
Mounjaro	Not covered	Might be covered for type 2 diabetes	[1] [2]

Who qualifies for the Bridge

• You have Medicare Part D drug coverage and are 18 or older ^[2].
• Your BMI is 35 or higher; or 30 or higher with heart failure with preserved ejection fraction, uncontrolled high blood pressure, or chronic kidney disease stage 3a or worse; or 27 or higher with prediabetes, a past heart attack or stroke, or symptomatic peripheral artery disease ^[2].
• You do not have type 2 diabetes, moderate to severe sleep apnea or fatty liver disease (MASH); those patients use their regular Part D plan ^[2].
• Your prescriber confirms you are in a diet and exercise lifestyle program ^[2].

How the Bridge works in practice

• Prior authorization is processed centrally by Humana, with a decision within 72 hours. Approval lasts through Dec 31, 2027 unless you switch drugs ^[1].
• Fills are 28- or 30-day supplies only, with no 90-day fills, and pharmacies do not have to opt in ^[1].
• The $50 copay does not count toward your Part D deductible or out-of-pocket cap, is not reduced by Extra Help, cannot be paid through the Medicare Prescription Payment Plan, and coupons cannot be applied ^[2].
• Pen needles are not covered ^[1].
• The Bridge was first set for six months and was extended to 18 months in April 2026 ^[6]. NCOA reports makers supply Bridge drugs at a net price of about $245 a month ^[7].

Medicare without the Bridge

If you do not qualify, maker savings cards are off the table: Lilly and Novo exclude Medicare members from their $25 offers ^{[4] [5]}. You can still pay self-pay prices, such as $299 to $449 for Zepbound on LillyDirect ^[8] or $349 for Wegovy pens on NovoCare ^[5]. Lilly said eligible Part D members may get Foundayo for $50 a month from July 1, 2026 ^[9]. Compare every route in the GLP-1 Price Tracker.

Two approvals matter here. The FDA approved Wegovy to reduce heart attack, stroke and cardiovascular death risk in adults with heart disease and obesity or overweight on March 8, 2024 ^[10], and Zepbound for moderate to severe sleep apnea with obesity on Dec 20, 2024 ^[11]. Ask your Part D plan whether it covers the drug for those uses.

Medicaid coverage by state

As of January 2026, 13 state Medicaid programs covered GLP-1s for obesity, down from 16 in October 2025. California, New Hampshire, Pennsylvania and South Carolina ended coverage, and North Carolina dropped it and then brought it back ^[3]. Medicaid may still cover GLP-1s for type 2 diabetes or other approved uses where obesity coverage ended, as South Carolina and California do ^{[12] [13]}. We could not confirm any state's Medicaid status after April 2026 except Massachusetts and Utah, so treat the covered states below as last known status.

Medicaid coverage of GLP-1s for obesity, selected states

State	Status	Detail	Source
Tennessee	Covered as of April 2026	TennCare covers Wegovy and Zepbound with prior authorization for BMI of 30 or more, or 27 or more with a related condition, since Aug 1, 2025	[14]
North Carolina	Covered as of Dec 2025	Dropped Oct 1, 2025, reinstated Dec 12, 2025. Wegovy preferred; Zepbound needs a Wegovy trial first.	[15]
Minnesota, Missouri, Virginia	Covered as of April 2026	Named among covering states in April 2026	[16]
Michigan	Limited as of Jan 2026	Since Jan 1, 2026, only for members with morbid obesity who failed other treatments, to avoid bariatric surgery	[17]
Utah	Not covered for weight alone	Pilot ended with reauthorizations through June 30, 2026. Wegovy (heart, MASH) and Zepbound (sleep apnea) still covered with prior authorization.	[18]
Massachusetts	Not covered for weight alone	Ended July 3, 2026. Still covered for BMI over 27 with heart disease, BMI over 30 with sleep apnea, MASH, and under 21.	[19]
California	Not covered for adult weight loss	Ended Jan 1, 2026; members under 21 still covered	[13]
Pennsylvania	Not covered for weight	Ended Jan 1, 2026; other GLP-1 uses need prior authorization	[20]
South Carolina	Not covered for weight	Ended Jan 1, 2026; diabetes coverage continues	[12]
Arizona, Colorado, DC, Florida, Georgia, Illinois, Indiana, Maryland, Nevada, New Jersey, New York, Ohio, Oregon, Washington	Not covered for obesity	Not among the 13 programs KFF counted as covering obesity GLP-1s in January 2026	[3]
Louisiana, New Mexico, Texas	Not covered for obesity	KFF lists these as covering some weight-loss drugs but no GLP-1s for obesity	[3]

Commercial insurance

For job-based and individual plans, coverage depends on whether your employer or plan added obesity drugs and on its prior authorization rules. Lilly, citing an IFEBP survey, says about half of Americans with employer coverage lack coverage for obesity medicines ^[9]. If your plan covers the drug, maker savings cards can bring the cost to $25 ^{[4] [5]}. Step-by-step guides: Wegovy, Zepbound and Mounjaro, Ozempic.

We may earn a commission if you sign up through some links on this page. It never changes a verdict. How we make money

See Form Health prices

Programs that accept Medicare or insurance (clean or caution only)

1. FForm Health

   Clean

   Price

   $299 a month self-pay; insurance including Medicare accepted ^[23]

   What you get

   Clinician and dietitian visits; brand drugs only

   FDA record

   No FDA warning letter found as of Oct 17, 2026

   BBB

   Not yet checked

   Note

   Labs and drugs extra

   Visit Form Health

2. KKnownwell

   Clean

   Price

   Average $25 visit copay with insurance; no self-pay price published

   What you get

   Obesity medicine visits, in person and virtual

   FDA record

   No FDA warning letter found as of Oct 17, 2026

   BBB

   Not yet checked

   Note

   Prescribes brand GLP-1s only

   Visit Knownwell

Related: Foundayo, Wegovy cost, Zepbound cost.